Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients

被引：0
|
作者：
Yusuf, S. J. [1 ]
Bheemreddy, H. [1 ]
Imtiaz, A. [2 ]
Krishnan, N. [3 ]
机构：
[1] Coventry Univ, Fac Hlth & Life Sci, Coventry, W Midlands, England
[2] Univ Hosp Coventry & Warwickshire NHS Trust, Dermatol, Coventry, W Midlands, England
[3] Univ Hosp Coventry & Warwickshire NHS Trust, Renal Unit, Coventry, W Midlands, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A-225
引用
收藏
页码：831 / 831
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
    Zhang, Jun
    Sun, Zhi
    Zhu, Zhenfeng
    Yang, Jing
    Kang, Jian
    Feng, Guiwen
    Zhou, Lin
    Zuo, Lihua
    Luo, Yonggang
    Zhang, Xiaojian
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [42] Kidney Transplant Recipients with Diabetic Mellitus Demand Larger Doses of Mycophenolate Mofetil.
    Takamoto, D.
    Sasaki, H.
    Harada, S.
    Takada, Y.
    Harada, H.
    Tsujimoto, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1088 - 1088
  • [43] Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients
    Navascués, RA
    Gómez, E
    Rodriguez, M
    Laures, AS
    Baltar, J
    Grande, JA
    [J]. NEPHRON, 2002, 91 (01) : 173 - 174
  • [44] Safety and Efficacy of a Preemptive Mycophenolate Mofetil Dose Reduction Strategy in Kidney Transplant Recipients
    Yatim, Karim
    Al Jurdi, Ayman
    El Mouhayyar, Christopher
    Morena, Leela
    Hullekes, Frank E.
    Verhoeff, Ruchama
    Ribas, Guilherme T.
    Pearson, Daniel S.
    V. Riella, Leonardo
    [J]. TRANSPLANTATION DIRECT, 2024, 10 (09):
  • [45] Pharmacometabolomics identified nonactivated metabolites of azathioprine and mycophenolate mofetil in urine of kidney transplant recipients
    Klont, Frank
    Bakker, Stephan J. L.
    Hak, Eelko
    Touw, Daan J.
    Hopfgartner, Gerard
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1616 - I1616
  • [46] Effect of mycophenolate mofetil regimen on peripheral blood lymphocyte subsets in kidney transplant recipients
    Soto, JAB
    de la Rosa, RJE
    del Castillo, JDL
    Morales, SC
    Olivares, EG
    Ortega, AO
    Peinado, CA
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) : 1355 - 1359
  • [47] Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft
    Grinyo, JM
    Gil-Vernet, S
    Seron, D
    Hueso, M
    Fulladosa, X
    Cruzado, JM
    Moreso, F
    Fernandez, A
    Torras, J
    Riera, L
    Castelao, AM
    Alsina, J
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (10) : 2601 - 2604
  • [48] Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine
    Fabrega, AJ
    Corwin, CL
    Hunsicker, L
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1562 - 1563
  • [49] Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients
    Rerolle, Jean-Philippe
    Szelag, Jean-Christophe
    Le Meur, Yann
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (02) : 671 - 672
  • [50] Concomitant Proton Pump Inhibitors With Mycophenolate Mofetil and the Risk of Rejection in Kidney Transplant Recipients
    Knorr, John P.
    Sjeime, Mariel
    Braitman, Leonard E.
    Jawa, Pankaj
    Zaki, Radi
    Ortiz, Jorge
    [J]. TRANSPLANTATION, 2014, 97 (05) : 518 - 524
12345